These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 591759)
1. [Symposium on pathophysiology of biliary tract diseases with special emphasis on gallstone disease. (6) Basic and clinical studies on bile acid preparations for the treatment of gallstones (author's transl)]. Kajiyama G; Maruhashi A Nihon Naika Gakkai Zasshi; 1977 Sep; 66(9):1201-5. PubMed ID: 591759 [No Abstract] [Full Text] [Related]
2. [Symposium on pathophysiology of biliary tract diseases with special emphasis on gallstone disease. Supplementary (1) Changes of bile acid metabolism by administration of chenodeoxycholic acid and ursodeoxycholic acid (author's transl)]. Nakagawa S; Makino I Nihon Naika Gakkai Zasshi; 1977 Sep; 66(9):1206-8. PubMed ID: 591760 [No Abstract] [Full Text] [Related]
3. [Changes in biliary bile acid composition and cholesterol saturation of bile in patients with cholesterol gallstones following treatment with ursodeoxycholic acid]. Stiehl A; Czygan P; Fröhling W; Kommerell B Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():501-2. PubMed ID: 612017 [No Abstract] [Full Text] [Related]
5. Effect of litholytic bile acids on cholesterol absorption in gallstone patients. LaRusso NF; Thistle JL Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406 [TBL] [Abstract][Full Text] [Related]
6. [Comparison of the effects of an equal dose of 15 mg/kg/day of chenodeoxycholic and ursodeoxycholic acid on the composition of biliary lipids and acids in the bile in radiotransparent biliary lithiasis]. Garrido G; Breto M; Alegre B; Pérez Aguilar F; Berenguer J Rev Esp Enferm Apar Dig; 1983 Oct; 64(4):261-9. PubMed ID: 6658120 [No Abstract] [Full Text] [Related]
7. Ursodeoxycholic acid versus chenodeoxycholic acid. Comparison of their effects on bile acid and bile lipid composition in patients with cholesterol gallstones. Stiehl A; Czygan P; Kommerell B; Weis HJ; Holtermüller KH Gastroenterology; 1978 Dec; 75(6):1016-20. PubMed ID: 30674 [No Abstract] [Full Text] [Related]
8. Biliary lipid metabolism in gallstone disease and during gallstone dissolution treatment. Nilsell K Acta Chir Scand Suppl; 1985; 528():1-38. PubMed ID: 3866449 [No Abstract] [Full Text] [Related]
9. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones. Iwamura K Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199 [TBL] [Abstract][Full Text] [Related]
10. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid. Stiehl A; Raedsch R; Czygan P; Götz R; Männer C; Walker S; Kommerell B Gastroenterology; 1980 Dec; 79(6):1192-8. PubMed ID: 7439628 [TBL] [Abstract][Full Text] [Related]
11. [Cholelithiasis treated with chenodeoxycholic acid. An analysis of changes in the pattern of bile acids (author's transl)]. Hrabák P; Dosková M; Soucková E Cas Lek Cesk; 1981 Jul; 120(27):817-23. PubMed ID: 7261002 [No Abstract] [Full Text] [Related]
12. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study. Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826 [TBL] [Abstract][Full Text] [Related]
13. Changes in serum bile acids during treatment with chenodiol or ursodiol for dissolution of cholesterol gallstones. Nowak M; Panveliwalla D; Pertsemlidis D Mt Sinai J Med; 1983; 50(3):240-4. PubMed ID: 6604868 [No Abstract] [Full Text] [Related]
14. [Symposium on pathophysiology of biliary tract diseases with special emphasis on gallstone disease. Supplementary (2) Serum lipids and the pattern of lipoproteins in cholelithiasis and their relation to the compositional change of bile and bile acids (author's transl)]. Yamamoto A; Kaki-Uchi Y Nihon Naika Gakkai Zasshi; 1977 Sep; 66(9):1209-11. PubMed ID: 591761 [No Abstract] [Full Text] [Related]
16. [Treatment of gallstone with ursodeoxycholic acid--lipid and bile acid composition in bile (author's transl)]. Tanikawa K; Maeyama T; Abe H; Anno H; Okumura M; Chuman Y; Koji T; Nakagawa S; Nakamura Y; Iino H; Yamasaki S; Hisatsugu T Nihon Shokakibyo Gakkai Zasshi; 1978 Aug; 75(8):1196-203. PubMed ID: 722960 [No Abstract] [Full Text] [Related]
17. Gallstone dissolution and the cholesterol--bile acid--lipoprotein axis. Propitious effects of ursodeoxycholic acid. Fromm H Gastroenterology; 1984 Jul; 87(1):229-33. PubMed ID: 6724267 [No Abstract] [Full Text] [Related]
18. [New therapeutic methods--technics, application, efficacy and problems. Litholysis. a) Theory of litholysis and development of litholytic agents]. Makino I; Yoneda M; Tamasawa N; Takebe K Nihon Rinsho; 1987 Jul; 45(7):1539-46. PubMed ID: 3669350 [No Abstract] [Full Text] [Related]
19. [Symposium on pathophysiology of biliary tract diseases with special emphasis on gallstone disease. (5) The kinetic study of bile acids in patients with cholesterol gallstone (author's transl)]. Hatta Y; Saito H; Shimizu M Nihon Naika Gakkai Zasshi; 1977 Sep; 66(9):1196-200. PubMed ID: 591758 [No Abstract] [Full Text] [Related]
20. [Comparative study of the effects of an average dose of chenodesoxycholic acid and a high dose of ursodesoxycholic acid (dosage equivalents: 15 mg/kg/day) on the composition of lipids and bile acids in the bile of patients with radiotransparent biliary lithiasis]. Garrido G; Bretó M; Pérez F; Berenguer J Rev Clin Esp; 1983 Jul 15-31; 170(1-2):31-6. PubMed ID: 6635274 [No Abstract] [Full Text] [Related] [Next] [New Search]